Regentis Biomaterials Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RGNT | SMTI | AMS.L | 0876.HK | BLFS | CLGN | |
|---|---|---|---|---|---|---|
| Market cap | 9.27M | 297.05M | 616.70M | 151.30M | — | 12.18M |
| P/E (TTM) | — | — | 141.6 | — | — | — |
| Forward P/E | — | 59.9 | 16.7 | — | — | -10.8 |
| Price/book | 1.2 | 37.4 | 2.4 | -0.5 | — | 2.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −81.73% | +16.56% | +31.09% | −55.76% | — | −81.23% |
| Today | −3.65% | +0.50% | +0.05% | 0.00% | 0.00% | +2.92% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All RGNT news ›Regentis Biomaterials (NYSE American: RGNT) to Present at 2026 ThinkEquity Conference on Oct. 15
Austin, Texas, October 12th, 2026, FinanceWireRegentis Biomaterials (NYSE American: RGNT), a regenerative medicine company fo... Regentis Biomaterials (NYSE American: RGNT) to Present at 2026 ThinkEquity Conference on Oct. 15 Austin,…
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
HERZLIYA, IL / ACCESS Newswire / October 9, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE ... Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City HERZLIYA, IL / ACCESS…
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
Engagement with leading orthopedic surgeons and cartilage repair specialists highlights growing awareness of GelrinC's ... Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal Engagement with…
Regentis Biomaterials to Present at 2026 ThinkEquity Conference, Highlighting GelrinC Progress
citybuzz - Regentis Biomaterials Ltd. (NYSE American: RGNT), a regenerative medicine company focused on innovative tissue repair solutions, will present at the 2026 ThinkEquity Conference on October 15, 20
Regentis Biomaterials Aims to Transform Knee Cartilage Repair with Resorbable Hydrogel
citybuzz - Regentis Biomaterials Ltd. (NYSE American: RGNT) is developing GelrinC, an acellular hydrogel implant designed to repair knee cartilage damage by shifting treatment from symptom management to early stru
BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair
About Regentis Biomaterials Ltd. This content has been disseminated on behalf of Regentis Biomaterials Ltd. (NASDAQ: RGNT) as part of a paid investor awareness and marketing engagement. NOTE TO INVESTORS: The latest news and updates…
InvestorNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial Case for GelrinC in Multi-Billion Knee Cartilage Repair Market
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Regentis Biomaterials (NYSE American: RGNT) was ... Regentis Biomaterials (NYSE American:…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- markets.financialcontent.com2
- stocktitan.net2
- citybuzz.co1
- digitaljournal.com1
- markets.businessinsider.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.